CRYSTAL BYINGTON: Open Payments
NPI 1841535812 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$761 in 9 payments from 3 companies in 2025. Trend: 2023 $1,457 · 2024 $1,137 · 2025 $761
Food & beverage: $761
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 5 | $357 |
| AstraZeneca Pharmaceuticals LP | 3 | $279 |
| Alexion Pharmaceuticals, Inc. | 1 | $125 |
Products named: FASENRA, Yeztugo, ULTOMIRIS.
Industry payments across WI — which companies pay providers there.
